{"title":"雇主努力应对生物制剂使用量的增加:成本分担或更高的免赔额的权衡可能会破坏治疗并降低医疗保健支出的价值。","authors":"Lola Butcher","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Employers have tried everything from uptiering to tighter utilization management in trying to mitigate the high cost of biologics. They now hope that biosimilars may offer some relief. But there's another option - one they should take a hard look at.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 4","pages":"21-4"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278132/pdf/bh0804021.pdf","citationCount":"0","resultStr":"{\"title\":\"Employers Struggle To Cope With the Rising Use of Biologics: Tradeoffs in cost sharing or higher deductibles could derail treatment and decrease the value of healthcare spending.\",\"authors\":\"Lola Butcher\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Employers have tried everything from uptiering to tighter utilization management in trying to mitigate the high cost of biologics. They now hope that biosimilars may offer some relief. But there's another option - one they should take a hard look at.</p>\",\"PeriodicalId\":89534,\"journal\":{\"name\":\"Biotechnology healthcare\",\"volume\":\"8 4\",\"pages\":\"21-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278132/pdf/bh0804021.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology healthcare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology healthcare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Employers Struggle To Cope With the Rising Use of Biologics: Tradeoffs in cost sharing or higher deductibles could derail treatment and decrease the value of healthcare spending.
Employers have tried everything from uptiering to tighter utilization management in trying to mitigate the high cost of biologics. They now hope that biosimilars may offer some relief. But there's another option - one they should take a hard look at.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
